Impact assessment in a non-government organisation

<p>Supplemental_figure for A Simple Scoring System Using the Red Blood Cell Distribution Width, Delta Neutrophil Index, and Platelet Count to Predict Mortality in Patients With Severe Sepsis and Septic Shock by Yong Chan Kim, Je Eun Song, Eun Jin Kim, Heun Choi, Woo Yong Jeong, In Young Jung, Su Jin Jeong, Nam Su Ku, Jun Yong Choi, Young Goo Song, and June Myung Kim in Journal of Intensive Care Medicine</p

Correlation between LSM values and other variables.

<p><b>NOTE.</b>^aPearson’s correlation coefficient, ^bCorrelation analyses in only patients who has ever been received each antiretroviral drug, ^cSpearman’s ρ. LSM, liver stiffness measurement; cART, combined antiretroviral treatment; INR, international normalized ratio; NRTIs, nucleoside analogue reverse transcriptase inhibitors; NNRTIs, non-nucleoside analogue reverse transcriptase inhibitors; PIs, protease inhibitors.</p

Comparisons of baseline characteristics and cumulative exposure durations of antiretroviral drugs between patients with normal and abnormal LSM values.

<p><b>NOTE.</b> Data are expressed as mean ± SD or number (percent). ^aIndependent sample two T-test, ^bFisher’s exact test, ^cChi-square test, and ^dMann-Whitney U-test were used.^eThe undetectable range was defined as fewer than 20 copies/mL. LSM, liver stiffness measurement; cART, combined antiretroviral treatment; INR, international normalized ratio; NNRTI, non-nucleoside analogue reverse transcriptase inhibitor; cART, combined antiretroviral treatment; PI, protease inhibitors; NRTI, nucleoside analogue reverse transcriptase inhibitor.</p

Supplemental_table_2 - A Simple Scoring System Using the Red Blood Cell Distribution Width, Delta Neutrophil Index, and Platelet Count to Predict Mortality in Patients With Severe Sepsis and Septic Shock

<p>Supplemental_table_2 for A Simple Scoring System Using the Red Blood Cell Distribution Width, Delta Neutrophil Index, and Platelet Count to Predict Mortality in Patients With Severe Sepsis and Septic Shock by Yong Chan Kim, Je Eun Song, Eun Jin Kim, Heun Choi, Woo Yong Jeong, In Young Jung, Su Jin Jeong, Nam Su Ku, Jun Yong Choi, Young Goo Song, and June Myung Kim in Journal of Intensive Care Medicine</p

Recruitment flow of study participants for this study.

<p><b>NOTE.</b> LSM, liver stiffness measurement; HBV, hepatitis B virus; HCV, hepatitis C virus; HAV, hepatitis A virus; OI, opportunistic infection; AIDS, acquired immunodeficiency syndrome; cART, combined antiretroviral treatment.</p

Baseline characteristics and antiretroviral drug regimens of study participants upon LSM examination (n = 93).

<p><b>NOTE.</b> Data are expressed as mean ± SD, number (percent), or median (interquartile range). LSM, liver stiffness measurement; cART, combined antiretroviral treatment; AIDS, Adult immunodeficiency syndrome; CDC, Centers for Disease Control and Prevention; kPa, kilopascal; INR, international normalized ratio; NRTIs, nucleoside analogue reverse transcriptase inhibitors; NNRTIs, non-nucleoside analogue reverse transcriptase inhibitors; PIs, protease inhibitors. ^aA change to co-formulated drugs with the same components was not considered to be a change in antiretroviral drugs.</p

Multivariate logistic regression analysis to identify the independent predictors of abnormal LSM values.

<p>Included variables in this final model: Cumulative exposure duration of boosted-PIs, γ-glutamyltranspeptidase, total bilirubin, time period since HIV infection diagnosis, and prothrombin time. LSM, liver stiffness measurement; OR, odds ratio; CI, confidence interval; PIs, protease inhibitors.</p

Distribution of LSM values among all study participants.

<p><b>NOTE.</b> The dotted line indicates the cutoff value for abnormal LSM (5.3 kPa). LSM, liver stiffness measurement; kPa, kilopascal.</p

Percentage of patients with abnormal LSM values according to cutoff values of the cumulative exposure duration of boosted-PIs (a) and γ-GT level (b).

<p>Percentage of patients with abnormal LSM values according to cutoff values of the cumulative exposure duration of boosted-PIs (a) and γ-GT level (b).</p

Additional file 1: of Comparison of the efficacy of nafcillin and glycopeptides as definitive therapy for patients with methicillin-susceptible Staphylococcus aureus bacteremia: a retrospective cohort study

Supplement 1. Antibiotic resistance rate of identified Staphylococcus aureus. (DOCX 21 kb